
NMPA Approved Drugs List – February 2026: 3 Innovative Drugs Approved in China
According to the National Medical Products Administration (NMPA), three innovative drugs were approved for marketing…

According to the National Medical Products Administration (NMPA), three innovative drugs were approved for marketing…

Against the backdrop of the ongoing restructuring of the global pharmaceutical supply chain, China is…

In the context of increasingly stringent global pharmaceutical regulations, choosing a licensed Pharmaceutical Distributor in…

In 1852, French physician Duchenne described boys with progressive muscle weakness whose enlarged calves were…

In today’s increasingly competitive global pharmaceutical landscape, choosing a reputable pharmaceutical wholesaler has become a…

Lung cancer remains the leading cause of cancer death worldwide, with non-small cell lung cancer…

Before the advent of targeted therapy, ALK-positive advanced non-small cell lung cancer (NSCLC) typically progressed…

Epidermal growth factor receptor EGFR–targeted drugs represent a cornerstone in the treatment of advanced non–small…

In May 2023, China’s National Medical Products Administration (NMPA) approved the first domestically developed generic…

In recent years, rare disease treatment has rapidly risen from a niche medical issue to…